Dinja T Kruger

2PUBLICATIONS
24CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao

|Sep 07, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.

Dinja T Kruger, Xanthippi Alexi, Mark Opdam

Pageof 1

Frequent Collaborators

2 joint publications

Sabine C Linn

1 joint publications

Jinhyuk Bhin

1 joint publications

Julia Yemelyanenko

1 joint publications

Xue Chao